Accepting Applications for the 2020 ANA Innovation Awards, Powered by BD
Silver Spring, MD— The American Nurses Association (ANA) and the American Nurses Foundation (the Foundation) are now accepting applications for the 2020 ANA Innovation Awards, powered by BD (Becton, Dickinson and Company), a leading global medical technology company. The application process is open through January 15, 2020.
The ANA Innovation Awards include a $25,000 individual nurse award and a $50,000 nurse-led team award for a product, program, project or practice that improves patient outcomes and safety, and exemplify nurse-led innovation. These funds will provide support in translational research, development, prototyping, production, testing and implementation over the next year.
Representing the largest group of health care professionals in the U.S. and providing care on the frontlines to millions, nurses offer an unmatched perspective on what works and what doesn’t work. Nurses have a tremendous amount of input, feedback and thought leadership to offer around not only the development of processes, systems and devices, but also in anticipating and solving the issues that impact their patients and communities.
The winner of the 2019 Individual Nurse Award, Kathleen Puri, created Fitsi - a bedside caddy that allows patients to easily clean their own hands and access their personal items without the assistance of a caregiver. Fitsi can help reduce the risk of infection and patient falls, while improving the patient experience and saving providers’ time. Michael Wang and Paul Coyne won the Nurse-led Team Award for iN, a wall mounted computer behind the patient’s bed that detects potential risks to patients and aggregates data from Electronic Health Records and other medical devices. Through predictive algorithms, iN is designed to help address preventable patient injuries and mitigate unnecessary medical errors.
ANA and the Foundation are grateful to our partner BD for their commitment to nursing innovation. BD celebrates nurses’ influence and their innovative solutions to improve and transform nursing practice and patient safety. The company’s generous contribution to the Foundation and commitment to advancing medication management is in direct support of ANA’s Innovation Framework, which aims to cultivate nurse-led innovation and solutions that address the complexities of health care delivery.
“BD applauds the American Nurses Association for their commitment to Nursing Innovation that aims to improve patient outcomes and safety,” said Kelly Larrabee-Robke, RN. MBA, MS, Vice President of Clinical Thought Leadership. “Nurses are leaders in managing care delivery and as advocates for our patients. Nurses are actively driving innovation into reality, as leaders in addressing the challenges and opportunities present in care delivery. We look forward to continuing to partner with the ANA in supporting the vital efforts of the Nursing Innovation community in driving discovery and radical thinking in health care delivery.”
Applications will be accepted through January 15, 2020 and evaluated by a blind, peer-review process conducted by a panel of national experts. Learn more about the awards criteria and apply today.
# # #
About the American Nurses Association
The American Nurses Association (ANA) is the premier organization representing the interests of the nation's 4 million registered nurses. ANA advances the nursing profession by fostering high standards of nursing practice, promoting a safe and ethical work environment, bolstering the health and wellness of nurses, and advocating on health care issues that affect nurses and the public. ANA is at the forefront of improving the quality of health care for all. For more information, visit www.nursingworld.org.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com.